These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17414637)

  • 1. Reirradiation in squamous cell head and neck cancer: recent developments and future directions.
    Langendijk JA; Bourhis J
    Curr Opin Oncol; 2007 May; 19(3):202-9. PubMed ID: 17414637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on re-irradiation for recurrent and second primary head and neck cancer.
    Kasperts N; Slotman B; Leemans CR; Langendijk JA
    Oral Oncol; 2005 Mar; 41(3):225-43. PubMed ID: 15743686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
    Langendijk JA; Kasperts N; Leemans CR; Doornaert P; Slotman BJ
    Radiother Oncol; 2006 Mar; 78(3):306-12. PubMed ID: 16524634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma.
    Suh JD; Kim BP; Abemayor E; Sercarz JA; Nabili V; Liu JH; Juillard GJ; Blackwell KE
    Otolaryngol Head Neck Surg; 2008 Dec; 139(6):781-6. PubMed ID: 19041503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
    Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
    J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
    Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
    J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer.
    Watkins JM; Stuart RK; Davis BK; Day TA; Chaudharry UB; Sharma AK
    J S C Med Assoc; 2008 Feb; 104(2):36-9. PubMed ID: 18396601
    [No Abstract]   [Full Text] [Related]  

  • 9. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
    Wong SJ; Machtay M; Li Y
    J Clin Oncol; 2006 Jun; 24(17):2653-8. PubMed ID: 16763279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
    Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
    J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck.
    Spencer SA; Harris J; Wheeler RH; Machtay M; Schultz C; Spanos W; Rotman M; Meredith R; Ang KK
    Head Neck; 2008 Mar; 30(3):281-8. PubMed ID: 17764087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer.
    Langer C; Damsker J; Ridge A
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):424-9, 440. PubMed ID: 16258428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
    Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
    Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
    Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
    J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.
    Salama JK; Vokes EE
    Semin Oncol; 2008 Jun; 35(3):251-61. PubMed ID: 18544440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
    McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
    Salama JK; Vokes EE; Chmura SJ; Milano MT; Kao J; Stenson KM; Witt ME; Haraf DJ
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):382-91. PubMed ID: 16213104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative reirradiation for mucosal head and neck squamous cell carcinomas.
    Iseli TA; Iseli CE; Rosenthal EL; Caudell JJ; Spencer SA; Magnuson JS; Smith AN; Carroll WR
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1158-64. PubMed ID: 19917931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.